Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been nearly a year since my last LifeMD (NASDAQ: LFMD ) article , where I discussed the company’s Weight Management Program and how that could impact their potential timeline for profitability. Since then, LFMD is up roughly 46% after theirHe is t ...

Bundled Offer Includes Wegovy® at $199 and LifeMD’s Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month ThereafterNEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes both the medication and access to LifeMD’s virtual weight management program. As part of its collaboration with N ...

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of May: H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York City. Management will be holding one-on-one meetings with investors.B. Riley Securities 25th Annual Institutional Investor Conference, May 21-22 at the Ritz-Carlton in Marina Del Rey ...

LifeMD, which belongs to the Zacks Medical Services industry, posted revenues of $65.7 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 5.20%. This compares to year-ago revenues of $44.14 million. The company has topped consensus revenue estimates three times over the last four quarters. LifeMD, Inc. (LFMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.19 per share a year ...

LifeMD (LFMD) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Company Participants Justin Schreiber - Chairman & CEOMarc Benathen - CFODavid Larsen - Managing DirectorSteve Dechert - AVP Conference Call Participants Sarah James - AnalystSteven Valiquette - MD & Senior Equity Research Analyst - Covering Health Care Technology & DistributionYi Chen - Managing Director & Senior AnalystAnderson Schock - Research Analyst Operator Good afternoon. Thank you for joining us today to discuss LifeMD's results for the f ...

FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the Transition Period from _________ to _________ Commission file number: 001-39785 LIFEMD, INC. (Exact name of registrant as specified in its charter) | | | (State or other Jurisdiction of Incorp ...

LifeMD (LFMD) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Speaker0 Good afternoon. Thank you for joining us today to discuss LifeMD's results for the first quarter ended 03/31/2025. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer and Mark Benethen, Chief Financial Officer. Following management's prepared remarks, we will open the call for a question and answer session. Before we begin, I would like to remind everyone that during this call, the company will make a number ...

Exhibit 99.1 LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance Conference call begins at 4:30 p.m. Eastern time today Management Commentary Justin Schreiber, Chairman and CEO of LifeMD, said, "LifeMD had an outstanding first quarter that demonstrated the power of our platform, the need for our services and the accelerated growth trajectory of the business as we achieved our first-ever quarter of GAAP profitability well ahead of expectations. During the quarter we expanded across a ...

Justin Schreiber, Chairman and CEO of LifeMD, said, "LifeMD had an outstanding first quarter that demonstrated the power of our platform, the need for our services and the accelerated growth trajectory of the business as we achieved our first-ever quarter of GAAP profitability well ahead of expectations. During the quarter we expanded across all service areas, and the performance of our weight management program underscored our success as it is now expected to exceed top- and bottom-line expectations for th ...

Shares of Hims & Hers Health (HIMS 23.96%) and LifeMD (LFMD 37.21%) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m. ET as the S&P 500 and the Nasdaq Composite showed modest gains.Shares soared after pharma giant Novo Nordisk announced it will distribute its blockbuster GLP-1 weight loss drug Wegovy through telehealth platforms like Hims & Hers and LifeMD.Wegovy is popularNovo Nordisk announced it will sell Wegovy directly through telehealth providers includ ...